Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J McConkey

Showing results (1-10 of 202) with videos related to

Pageof 21
Sort By:
Biochemical and Biophysical Research Communications|February 19, 2017
The integrated stress response and proteotoxicity in cancer therapyDavid J McConkey
Hematology/Oncology Clinics of North America|May 7, 2021
Molecular Biology of Bladder Cancer: Potential Implications for TherapyDavid J McConkey
Urologic Oncology|January 13, 2022
IntroductionDavid J McConkey
Nature Chemical Biology|August 20, 2008
20S ways to apoptosisDavid J McConkey
Cancer Cell|July 5, 2008
A novel role for a familiar protein in apoptosis induced by proteasome inhibitionDavid J McConkey
Cancer Cell|October 22, 2011
RAIDDing ER stress for oncolytic viral therapyDavid J McConkey
Blood|August 1, 2009
Bortezomib paradigm shift in myelomaDavid J McConkey
Advances in Experimental Medicine and Biology|November 13, 2007
Therapy-induced apoptosis in primary tumorsDavid J McConkey
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|September 27, 2008
Mechanisms of proteasome inhibitor action and resistance in cancerDavid J McConkey, Keyi Zhu
European Urology|October 28, 2018
ERCC2 Mutation: The Marker for Chemosensitivity in Primary and Secondary Muscle-invasive Bladder CancersWoonyoung Choi, David J McConkey
Pageof 21

Showing results (1-10 of 202) with videos related to

Sort By:
Pageof 21
Biochemical and Biophysical Research Communications|February 19, 2017
The integrated stress response and proteotoxicity in cancer therapyDavid J McConkey
Hematology/Oncology Clinics of North America|May 7, 2021
Molecular Biology of Bladder Cancer: Potential Implications for TherapyDavid J McConkey
Urologic Oncology|January 13, 2022
IntroductionDavid J McConkey
Nature Chemical Biology|August 20, 2008
20S ways to apoptosisDavid J McConkey
Cancer Cell|July 5, 2008
A novel role for a familiar protein in apoptosis induced by proteasome inhibitionDavid J McConkey
Cancer Cell|October 22, 2011
RAIDDing ER stress for oncolytic viral therapyDavid J McConkey
Blood|August 1, 2009
Bortezomib paradigm shift in myelomaDavid J McConkey
Advances in Experimental Medicine and Biology|November 13, 2007
Therapy-induced apoptosis in primary tumorsDavid J McConkey
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|September 27, 2008
Mechanisms of proteasome inhibitor action and resistance in cancerDavid J McConkey, Keyi Zhu
European Urology|October 28, 2018
ERCC2 Mutation: The Marker for Chemosensitivity in Primary and Secondary Muscle-invasive Bladder CancersWoonyoung Choi, David J McConkey
Pageof 21